/C O R R E C T I O N -- CordenPharma/

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

CordenPharmaInjection

More Like This

PR Newswire associated0

CordenPharma Expands Peptide Platform with more than 500 Million Euro Greenfield Facility Construction in the Basel Region of Switzerland

PR Newswire associated0

CordenPharma Invests €900m in Transformational Peptide Platform Expansion in the USA & Europe

PR Newswire associated0

CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity

PCI Pharma Services announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities.

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities

Business Wire logo

Argonaut Manufacturing Services Expands Aseptic Pharmaceutical Fill / Finish Capabilities with $45 Million Equity Investment from NewVale Capital and Telegraph Hill Partners

PR Newswire associated0

GBI Biomanufacturing Expands Capabilities with Automated Aseptic Fill-Finish for Drug Products

Kindeva Drug Delivery Completes Registration Batch at State-of-the-Art Aseptic Injectable Fill-Finish Facility

PR Newswire associated0

CordenPharma and Viking Therapeutics Sign Long-Term Strategic Partnership for Integrated Supply of GLP-1 Peptides, Injectables and Oral Formulations